Inicio/Acciones/CNSP

CNSP

USD

CNS Pharmaceuticals Inc. Common Stock

$6.600-0.420 (-5.983%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$7.020

Máximo

$7.020

Mínimo

$6.500

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

3.8M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.05M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $4.93Actual $6.600Máximo $114

Noticias Relacionadas

12 sept 2025 · 14:08

Analyst Upgrades

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

Maxim Group analyst Jason McCarthy upgrades CNS Pharma from Hold to Buy and announces $20 price target.

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

3 sept 2025 · 13:15

AccessWire

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

27 ago 2025 · 12:00

GlobeNewswire

IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of